ContactKontakt
    Home
    t2cure’s cell therapy is available through cooperating clinical centres
    t2cure cooperates with experienced partners in research and in the industry.
    t2cure's pipeline is built on clinical studies in cardiac and peripheral vascular indications
    t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics.

    Contact

    t2cure GmbH

    Susanne Knigge
    CEO

    Kennedyallee 93
    60596 Frankfurt am Main
    Germany

    Phone: +49-69-7561 4687 0
    Fax: +49-69-7561 4687 9
    E-mail: infot2cure.com